According to TechFlow, on September 4, the on-chain asset management protocol Enzyme Finance announced that it is acquiring a majority stake in the DeFi protocol MYSO Finance. The acquisition will enable Enzyme to provide customers with customized standby call options services, further expanding its business scope.
MYSO Finance is a protocol that aims to integrate DeFi and traditional financial concepts. Its MYSO v2 version implements a trust-minimized lending protocol on EVM and supports zero-liquidation lending (ZLL). This innovation allows users to conduct crypto-collateralized lending without facing liquidation risks.
As a user-friendly DeFi asset management system, Enzyme provides convenient access services for funds, investment clubs, DAO treasuries and enterprises. By integrating various protocols and simplifying the user's asset management experience, Enzyme is committed to reducing the complexity of interacting with DeFi and providing users with a more seamless operation experience.
